New and emerging ROS1-targeted therapies have expanded the treatment options for patients with ROS1-positive advanced non-small cell lung cancer (NSCLC). In this bite-sized Booster Quiz, test your knowledge on mechanisms of action of novel ROS1-targeted therapies, and clinical data to guide treatment selection. Receive immediate feedback and, following the quiz, download a summary of key supporting evidence.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/examining-advances-biomarker-driven-therapies-nsclc-micro-learning-approach
- Start Date: 2024-08-16 05:00:00
- End Date: 2024-08-16 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 89750.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest